DarioHealth Q2 ’20 Earnings Update
DarioHealth hosted its Q2 ’20 earnings call and discussed its business-to-business-to-consumer (B2B2C) channels, recent agreements for remote patient monitoring, and its differentiation from other platforms. Of note, management indicated that they currently have ~55k active users on the diabetes platform, up from 50k in Q1 ’20. Below, FENIX provides highlights and insights from the call.
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.